Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: results of monotherapy and combination therapy trials

Detalles Bibliográficos
Autores principales: Alecu, Iulian, Milenkova, Tsveta, Turner, Simon R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826089/
https://www.ncbi.nlm.nih.gov/pubmed/29505040
http://dx.doi.org/10.2147/DDDT.S156746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826089/
https://www.ncbi.nlm.nih.gov/pubmed/29505040
http://dx.doi.org/10.2147/DDDT.S156746

Ejemplares similares